Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.09 - $9.26
Previous CloseN/A
Volume261.88K
Average Volume (3M)1.29M
Market Cap
$1.91B
Enterprise Value$2.82B
Total Cash (Recent Filing)-$34.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)116.9
Beta1.02
Next Earnings
May 08, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding106,740,326
10 Day Avg. Volume2,009,503
30 Day Avg. Volume1,293,166
Standard Deviation0.19
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.40
Price to Cash Flow (P/CF)5.50
P/FCF Ratio6.70
Enterprise Value/Market Cap1.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.12
Enterprise Value/Ebitda19.29
Forecast
1Y Price Target
$6.81Price Target Upside36.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Management ExperienceThe new CEO and CFO have relevant healthcare industry experience, which could benefit the company's strategic direction.
Strategic InitiativesKey catalysts for GoodRx include progress on strategic initiatives like the hybrid retail pharmacy strategy and PBM partnerships.
Bears Say
Retail Pharmacy HeadwindsExpectations remain mixed due to continuing retail pharmacy headwinds and the uncertain pharmacy environment.
---
Ownership Overview
11.90% Insiders
14.77% Mutual Funds
0.58% Other Institutional Investors
62.46% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.09 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $1.91B.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is May 08, 2025 which is in 66 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Feb 27, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.091 by -$0.001.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 106,740,326 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.091. Following the earnings report the stock price went up 1.84%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
---
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.81 (36.75% Upside)
$6.81 (36.75% Upside)
Blogger Sentiment
Neutral
GDRX Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 919.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.02%
12-Months-Change
Fundamentals
Return on Equity
2.21%
Trailing 12-Months
Asset Growth
-12.63%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reveals significant growth and achievements in consumer reach, pharmacy partnerships, and financial metrics, with a few notable challenges in subscription revenue and ISP program expansion.Read More>---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$6.81
▲(36.75% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+11.91%
reiterated a sell rating 3 days ago
Copying Allen Lutz's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +11.91% per trade.
---